AVALO THERAPEUTICS

Welcome to the Brand page for “AVALO THERAPEUTICS”, which is offered here for Pharmaceutical preparations for the treatment of immunology, immune-mediated inflammatory diseases, oncology, and rare genetic disorders alone or in combination with biomarkers and companion diagnostics for targeted therapies approach to treatment; pharmaceutical preparations for the treatment of pediatric onset and rare and orphan disorders; pharmaceutical preparations for the treatment for autoimmune, auto-inflammatory, and immune-mediated diseases and conditions; pharmaceutical preparations for the treatment for immuno-oncology and oncology, monoclonal antibody targeted against il-18 for multiple myeloma, lung cancer, solid tumors, and hematologic cancers; pharmaceutical preparations for the treatment of genetic disorders;the wording avalo has no meaning in a foreign language.;therapeutics;.

Its status is currently believed to be active. Its class is unavailable. “AVALO THERAPEUTICS” is believed to be currently owned by “AVALO THERAPEUTICS, INC.”